Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's to shut plants

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31v39OW
via IFTTT